Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pyxis Oncology (PYXS) Gross Profit (2024 - 2025)

Pyxis Oncology (PYXS) has disclosed Gross Profit for 2 consecutive years, with $8.6 million as the latest value for Q4 2025.

  • Quarterly Gross Profit changed N/A to $8.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $11.5 million through Dec 2025, down 26.81% year-over-year, with the annual reading at $11.5 million for FY2025, 26.81% down from the prior year.
  • Gross Profit for Q4 2025 was $8.6 million at Pyxis Oncology, up from $2.8 million in the prior quarter.
  • The five-year high for Gross Profit was $15.7 million in Q1 2024, with the low at $2.8 million in Q2 2025.